NGM Biopharmaceuticals Shares Rebound From Monday's 52-Week Low, Up 13%
marketwatch.com
news
2022-10-18 17:03:00

By Stephen Nakrosis Shares of NGM Biopharmaceuticals, which hit a 52-week low on Monday, were trading higher on the Nasdaq Tuesday. On Monday, the stock finished with a 70.48% loss, after the company said a trial of NGM621 in patients with geographic atrophy secondary to age-related macular degeneration didn't meet its primary endpoint. NGM also said "NGM621 showed favorable safety and tolerability." During Monday's trading session, the company's shares touched a 52-week low of $2.92. At 12:51 p.
